Biopharma SHAKTI : Union Budget 2026
The Union Minister for Finance announced the launch of Biopharma Shakti initiative in budget 2026-27.
- ‘Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology & Innovation)’ is designed to develop India into a global biopharmaceutical manufacturing hub.
- This will build the ecosystem for domestic production of biologics and biosimilars.
- It will include a Biopharma-focused network with 3 new National Institutes of Pharmaceutical Education and Research (NIPER) and upgrading 7 existing ones.
- It will also create a network of India Clinical Trials sites.
- This initiative will catalyse investments in advanced biomanufacturing infrastructure, promote innovation and enhance India’s capabilities in high-value, next-generation therapies.
- It will focus on building a biopharma-centric innovation and manufacturing network, responding to India’s rapidly changing disease profile marked by a rising burden of non-communicable diseases such as diabetes, cancer and autoimmune disorders.
